The Most Recent Biotech IPOs To Keep An Eye On
Biotech IPOs have helped drug developers raise over $5 billion so far this year.
Alex Clarke
Insider Trading: The Most-Bought Mid-Caps Amid The Pandemic
Top five mid-cap companies that have been experiencing insider buying amid the coronavirus crisis.
With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?
With year-to-date gains of 2300%, 3300% and 3400%, respectively, the three stocks that are the focus of today’s article – two biotechs and a molecular… Read More »With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?
10 Under $10: “Cheap Stocks With Rich Paths Ahead”
When it comes to cheap stocks, the author of today’s article notes that “beyond the risks there is potential for big reward.” As such, she… Read More »10 Under $10: “Cheap Stocks With Rich Paths Ahead”
3 “Strong Buy” Pharma Stocks With Significant Upside Potential – And Catalysts Around The Corner
Regarding investor behavior amid the current market volatility, the author of today’s article observes that “A select group remains ready to take on some risk,… Read More »3 “Strong Buy” Pharma Stocks With Significant Upside Potential – And Catalysts Around The Corner
- « Previous
- 1
- …
- 10
- 11
- 12